CFDE Data Portal | Search RN7SL301P

	Label	Description
	RN7SL301P Gene (Entity type)	ENSG00000276014 - RNA, 7SL, cytoplasmic 301, pseudogene
	GSE213845 EZH2 inhibition 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE151083 enzalutamide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 7 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 3 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Spleen 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Spleen 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE183113 sorafenib 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

RN7SL301P

ENSG00000276014 - RNA, 7SL, cytoplasmic 301, pseudogene

GSE213845 EZH2 inhibition 4 v 0 human dn

A Gene Set from LINCS

GSE151083 enzalutamide 0 v 1 human up

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 5 v 1 human dn

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 2 v 1 human dn

A Gene Set from LINCS

GSE143782 calcitriol 7 v 11 human up

A Gene Set from LINCS

GSE77108 saha 3 v 7 human up

A Gene Set from LINCS

GTEx Spleen 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Spleen 20-29 vs 60-69 Up

A Gene Set from GTEx

GSE183113 sorafenib 2 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.